191 related articles for article (PubMed ID: 38355711)
21. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
22. Linc00514 promotes breast cancer metastasis and M2 polarization of tumor-associated macrophages via Jagged1-mediated notch signaling pathway.
Tao S; Chen Q; Lin C; Dong H
J Exp Clin Cancer Res; 2020 Sep; 39(1):191. PubMed ID: 32943090
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
24. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang JY; Lee JK; Jeon YK; Kim CW
BMC Cancer; 2013 Sep; 13():421. PubMed ID: 24044575
[TBL] [Abstract][Full Text] [Related]
25. XIAOPI formula inhibits the pre-metastatic niche formation in breast cancer via suppressing TAMs/CXCL1 signaling.
Zheng Y; Wang N; Wang S; Yang B; Situ H; Zhong L; Lin Y; Wang Z
Cell Commun Signal; 2020 Mar; 18(1):48. PubMed ID: 32213179
[TBL] [Abstract][Full Text] [Related]
26. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
[TBL] [Abstract][Full Text] [Related]
28. Leptin promotes breast cancer cell migration and invasion via IL-18 expression and secretion.
Li K; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T
Int J Oncol; 2016 Jun; 48(6):2479-87. PubMed ID: 27082857
[TBL] [Abstract][Full Text] [Related]
29. Tumor cells-derived conditioned medium induced pro-tumoral phenotypes in macrophages through calcium-nuclear factor κB interaction.
Zhang Y; Zhang Z; Chen L; Zhang X
BMC Cancer; 2022 Dec; 22(1):1327. PubMed ID: 36536301
[TBL] [Abstract][Full Text] [Related]
30. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
Lee C; Kim S; Jeong C; Cho I; Jo J; Han IH; Bae H
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216272
[TBL] [Abstract][Full Text] [Related]
31. A High Dose of Calcitriol Inhibits Glycolysis and M2 Macrophage Polarization in the Tumor Microenvironment by Repressing mTOR Activation: in vitro and Molecular Docking Studies.
Munir MT; Halim SA; Santos JM; Khan F; Khan A; Rahman MM; Hussain F; Al-Harrasi A; Gollahon LS; Rahman SM
Cell Physiol Biochem; 2023 Apr; 57(2):105-122. PubMed ID: 37052042
[TBL] [Abstract][Full Text] [Related]
32. Differential Impact of Calcitriol and Its Analogs on Tumor Stroma in Young and Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Cancer.
Anisiewicz A; Pawlik A; Filip-Psurska B; Wietrzyk J
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887237
[TBL] [Abstract][Full Text] [Related]
33. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.
Shrivastava R; Asif M; Singh V; Dubey P; Ahmad Malik S; Lone MU; Tewari BN; Baghel KS; Pal S; Nagar GK; Chattopadhyay N; Bhadauria S
Cytokine; 2019 Jun; 118():130-143. PubMed ID: 29625858
[TBL] [Abstract][Full Text] [Related]
34. Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1.
Kim SH; Kim SJ; Park J; Joe Y; Lee SE; Saeidi S; Zhong X; Kim SH; Park SA; Na HK; Chung HT; Surh YJ
Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33809707
[TBL] [Abstract][Full Text] [Related]
35. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis.
Chen XW; Yu TJ; Zhang J; Li Y; Chen HL; Yang GF; Yu W; Liu YZ; Liu XX; Duan CF; Tang HL; Qiu M; Wang CL; Zheng H; Yue J; Guo AM; Yang J
Oncogene; 2017 Aug; 36(35):5045-5057. PubMed ID: 28481877
[TBL] [Abstract][Full Text] [Related]
36. The miR-23a∼27a∼24-2 microRNA Cluster Promotes Inflammatory Polarization of Macrophages.
Boucher A; Klopfenstein N; Hallas WM; Skibbe J; Appert A; Jang SH; Pulakanti K; Rao S; Cowden Dahl KD; Dahl R
J Immunol; 2021 Feb; 206(3):540-553. PubMed ID: 33328213
[TBL] [Abstract][Full Text] [Related]
37. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
[TBL] [Abstract][Full Text] [Related]
38. Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin.
Kawaguchi Y; Ohshio Y; Watanabe A; Shiratori T; Okamoto K; Ueda K; Kataoka Y; Suzuki T; Hanaoka J
Cancer Sci; 2023 Mar; 114(3):750-763. PubMed ID: 36411518
[TBL] [Abstract][Full Text] [Related]
39. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
40. Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin.
Tripathi C; Tewari BN; Kanchan RK; Baghel KS; Nautiyal N; Shrivastava R; Kaur H; Bhatt ML; Bhadauria S
Oncotarget; 2014 Jul; 5(14):5350-68. PubMed ID: 25051364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
